degli Uberti E C, Trasforini G, Salvadori S, Margutti A, Teodori V, Rotola C, Tomatis R, Pansini R
Acta Endocrinol (Copenh). 1985 Jan;108(1):20-5. doi: 10.1530/acta.0.1080020.
The effects of iv somatostatin (somatotrophin release inhibiting factor (SRIF) on growth hormone (GH) and prolactin (Prl) response to dermorphin (D) were tested in 6 healthy men. In all subjects D induced a significant increase in GH and Prl levels, as expected. SRIF completely blocked the GH-releasing activity of D, whereas it only reduced the Prl-releasing activity. The results confirm that D is a potent stimulant for GH and Prl release in man, and furthermore demonstrate that the action of D on GH secretion can be completely overridden by SRIF.
在6名健康男性中测试了静脉注射生长抑素（促生长激素释放抑制因子（SRIF））对生长激素（GH）和催乳素（Prl）对德莫啡肽（D）反应的影响。如预期的那样，在所有受试者中，D均导致GH和Prl水平显著升高。SRIF完全阻断了D的GH释放活性，而仅降低了Prl释放活性。结果证实，D是人体中GH和Prl释放的有效刺激物，并且进一步证明SRIF可以完全抑制D对GH分泌的作用。
